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Abstract
Monogenic neurodevelopmental disorders provide key insights into the pathogenesis of disease 
and help us understand how specific genes control the development of the human brain. Timothy 
syndrome is caused by a missense mutation in the L-type calcium channel Cav1.2 that is 
associated with developmental delay and autism 1. We generated cortical neuronal precursor cells 
and neurons from induced pluripotent stem cells derived from individuals with Timothy 
syndrome. Cells from these individuals have defects in calcium (Ca2+) signaling and activity-
dependent gene expression. They also show abnormalities in differentiation, including decreased 
expression of genes that are expressed in lower cortical layers and in callosal projection neurons. 
In addition, neurons derived from individuals with Timothy syndrome show abnormal expression 
of tyrosine hydroxylase and increased production of norepinephrine and dopamine. This 
phenotype can be reversed by treatment with roscovitine, a cyclin-dependent kinase inhibitor and 
atypical L-type–channel blocker 2, 3, 4. These findings provide strong evidence that Cav1.2 
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regulates the differentiation of cortical neurons in humans and offer new insights into the causes of 
autism in individuals with Timothy syndrome.
Human genetic studies have implicated voltage-gated calcium channels, in particular the L-
type channel CaV1.2, in the development of psychiatric diseases such as autism5, bipolar 
disorder6 and schizophrenia7. Although calcium influx through these channels is important 
for a variety of neuronal processes including regulation of gene expression8, the cellular 
defects caused by mutations in these channels and how these defects lead to psychiatric 
symptoms is unknown. TS is caused by a point mutation in an alternatively spliced exon of 
CACNA1C, the gene that encodes the α1 subunit of Cav1.21. This mutation leads to 
decreased calcium- and voltage-dependent inactivation of the channel1,9. TS patients suffer 
from cardiac arrhythmia, hypoglycemia and global developmental delay. Over 60% of TS 
patients also fulfill the criteria for an autism spectrum disorder (ASD)1 making TS one of 
the most penetrant monogenic forms of autism.
To determine the cellular consequences of the TS mutation, we used somatic cell 
reprogramming10,11 to generate iPSCs from individuals with TS (see Supplementary Figs. 1, 
2, Methods and reference12 for characterization, and Supplementary Table 1 for a list of 
lines). We differentiated the iPSC lines into NPCs and neurons using conditions that favor 
the generation of cortical neurons13–15 (Fig. 1, Supplementary Fig. 3, and Methods for 
details on differentiation). To identify the types of cells in these cultures, we used Fluidigm 
Dynamic Arrays16 to measure the expression of region and cell-type specific marker genes 
in single cells (Fig. 1b; see Supplementary Table 2). The reliability and accuracy of this 
method for measuring single cell gene expression was verified in a variety of ways (see17, 
Supplementary Figs. 4, 5 and Methods). Overall, 64.9% of the cells at day 45 of 
differentiation in vitro expressed a neuronal marker (MAP2 or NCAM), and 76% of these 
cells were positive for the early neuronal marker Doublecortin (DCX)18. Individual neurons 
expressed combinations of genes that could be used to determine their neurotransmitter 
identity and cortical layer specificity (Fig. 1b lower). A substantial number of neurons 
expressed excitatory markers like VGLUT1 and VGLUT2 along with the dopamine receptor 
DRD2, whereas others expressed the inhibitory markers GAD65, GAD67 and VGAT.
The expression of FOXP1, ETV1, SATB2, CTIP2, CUX1 and RELN was used to define 
cortical layer identity, based on immunohistochemical analysis of human brains19,20 (Fig. 
1c). Ninety-one percent of the NCAM+ neurons expressed at least one cortical layer marker. 
The expression of ETV1 and FOXP1 was used to indicate a lower cortical layer identity, 
while the expression of CUX1, SATB2, CTIP2 and RELN in the absence of ETV1 and 
FOXP1 was used to define upper layer neurons. Approximately 85% of cortical neurons 
could be classified as lower layer neurons while the remaining 15% expressed markers of 
upper cortical layers (Fig. 1d). Among the lower layer neurons we could identify two 
distinct subpopulations (Fig. 1e): cells expressing CTIP2, which defines a population of 
subcortical projection neurons, and cells expressing SATB2, which defines neurons that 
project to distant cortical regions via the corpus callosum21–23.
A notable finding from this analysis was the remarkable reproducibility of the neuronal 
differentiation protocol across multiple iPSC lines and individuals (average standard 
Paşca et al. Page 2









deviation for the proportion of cells expressing a particular marker was 4.47%), indicating 
that single cell analysis of gene expression is reproducible and can be used to identify 
defects in neuronal differentiation.
The ability to generate well-defined populations of NPCs and neurons from iPSCs prompted 
us to ask whether we could identify cellular phenotypes associated with TS. We examined 
the proliferation (Supplementary Fig. 6a) and migration of NPCs (Supplementary Fig. 6b,c) 
and the total number of neurons generated (Supplementary Fig. 5), but found no differences 
between controls and TS cultures. We next used patch clamp recording and calcium imaging 
to assess the physiological properties of the neurons generated from iPSC lines (Fig. 1f). We 
found that 57% of the iPSC-derived cells fired mature action potentials (APs) 
(Supplementary Fig. 7). Comparison of TS and control neurons did not reveal any 
significant differences in AP threshold or amplitude, resting membrane potential, input 
resistance or capacitance (Supplementary Table 3). However, the APs of TS neurons were 
approximately 37% wider at the midpoint than those of controls (TS: 3.92 ± 0.49 versus 
Ctrl: 2.86 ± 0.12 ms, P = 0.008), which is consistent with a loss of channel inactivation (Fig. 
1f,g) and is similar to the defect we observed in TS-derived cardiomyocytes12.
We next examined intracellular calcium ([Ca2+]i) signals in TS and control NPCs and 
neurons using Fura-2 and time-lapse video microscopy. Because the cultures contain a 
mixed population of neurons and NPCs, we first measured [Ca2+]i in mature neurons 
expressing a YFP reporter gene under the control of the Synapsin-1 promoter (Fig. 1h). In 
TS cells we observed a significant increase in the sustained [Ca2+]i rise following 
depolarization that was abolished by treatment with nimodipine (Fig. 1i). This increased 
[Ca2+]i rise in TS neurons was observed in neurons derived from multiple lines and multiple 
independent differentiations (Supplementary Fig. 8a,b, Fig. 1j). Similarly, increased [Ca2+]i 
elevations were observed in TS-derived NPCs (Supplementary Fig. 8c,d). Taken together, 
these results provide strong evidence that NPCs and neurons derived from TS individuals 
have defects in AP firing and [Ca2+]I signaling.
CaV1.2 plays an important role in regulating activity-dependent gene expression in the 
nervous system8. We therefore used Illumina microarrays to compare the gene expression 
profile of TS and control NPCs and neurons (Fig. 2a–d). Hierarchical clustering based on 
differentially expressed genes showed that TS-derived cells clustered separately from 
controls. The expression levels of 211 genes in neurons (126 upregulated, 85 
downregulated) and 136 genes in NPCs (58 upregulated, 78 downregulated) were 
significantly altered in TS cells (Fig. 2c,d and Supplementary Table 4). Of the genes that 
were altered in TS neurons, 11 have been previously implicated in either ASD or intellectual 
disability (ID)24,25 (Supplementary Table 5).
We also identified 223 genes (135 upregulated, 88 downregulated) that were altered in TS 
relative to control neurons upon depolarization. A number of the genes that were altered in 
TS cells are linked to Ca2+-dependent regulation of the transcription factor CREB (Fig. 2e,f) 
including RSK/MSK and CAMKII. Others such as EGR1, FOS, FOSB, GAD67 and TH are 
downstream targets of CREB. In addition to TH, which is the rate-limiting enzyme in the 
production of dopamine and norepinephrine, DRD1IP (Calcyon), another gene involved in 
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dopamine signaling, was also upregulated in TS neurons. These results suggest that the TS 
mutation leads to misregulation of Ca2+-dependent gene expression and perturbs 
catecholamine signaling.
To determine whether the TS mutation leads to defects in neuronal differentiation, we used 
Fluidigm Arrays to study the identity of cells generated from individuals with TS versus 
controls (Fig. 3a). We found a significant decrease in the fraction of neurons expressing 
lower layer markers in TS relative to controls (TS: 66.7% versus Ctrl: 85.5%, P < 0.001; 
Fig. 3b), and an increase in the fraction of neurons expressing upper layer markers (TS: 
33.3% versus Ctrl: 14.5%, P = 0.002; Fig. 3b). TS cells expressing lower layer markers cells 
(Fig. 3c) contained a significantly lower proportion of SATB2 expressing cells (TS: 31.0% 
versus Ctrl: 55.3%, P < 0.001) and an increase in CTIP2 expressing cells (TS: 8.0% versus 
Ctrl: 1.0%, P = 0.01). Because SATB2 is both necessary and sufficient for the formation of 
callosal projection neurons21,22, this finding is consistent with the notion that the TS 
mutation decreases the fraction of callosal projection neurons and increases the number of 
cells that project to subcortical structures.
To validate these findings in vivo we also measured Satb2 expression in a transgenic mouse 
expressing the TS channel driven by the Foxg1 promoter in the forebrain (Supplementary 
Fig. 9). TS transgenic mice had a reduced number of Satb2 expressing cells that was most 
pronounced in lower layers (Fig. 3d–f), whereas Foxp1 expression (Fig. 3g) and the total 
number of NeuN expressing neurons in the cortex were unchanged. We therefore conclude 
that the TS mutation alters SATB2 expression both in vitro and in vivo. Interestingly, we did 
not observe an increase in the number of Ctip2 expressing cells in the TS channel-
expressing mice. This could be either because of differences between in vivo and in vitro 
neuronal differentiation or because of species-specific differences in Ctip2 regulation. 
CTIP2 is in fact expressed more broadly in humans, labeling cells in the subventricular zone 
as well as in cortical layers II and V26.
We also observed a significant increase in the fraction of cells that expressed TH in TS-
derived neuronal cultures (TS: 16.4% versus Ctrl: 8.0%, P = 0.03; Fig. 3a). This agrees with 
our earlier finding that genes involved in catecholamine synthesis are misregulated in TS. 
To determine whether the TS mutation alters the regulation of TH, we measured TH mRNA 
in TS and control neurons following electrical activation (Fig. 4a). After nine hours of 
stimulation, TH was downregulated in control neurons but upregulated in TS neurons, 
indicating that the TS mutation prevents down-regulation of TH in response to prolonged 
electrical activity. To provide evidence that this increase in TH mRNA has functional 
consequences we measured expression of TH protein using a TH specific antibody. We 
found that TS neuronal cultures contained 6.3 times more TH+ neurons (TH+/MAP2+ cells) 
than control cultures (Fig. 4b–d; TS: 15.03% ± 0.92%, n = 9 differentiations; Ctrl: 2.52% ± 
0.62%, n = 7 differentiations; t-test, P < 0.001 or than cultures generated from an individual 
with 22q11.2 deletion syndrome, another neurodevelopmental disorder (Fig. 4c). To 
determine whether this change in TH protein caused an increase in the production of 
catecholamines, we used high-pressure liquid chromatography (HPLC) to measure the level 
of norepinephrine and dopamine in the media collected from neuronal cultures. We found 
that the TS neurons secreted 3.5 times more norepinephrine (TS: 34.7 ± 4.02 × 10−5 versus 
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Ctrl: 9.79 ± 1.83 × 10−5 pg µl−1 neuron−1, t-test, P = 0.004) and 2.3 times more dopamine 
(TS: 4.56 ± 0.36 × 10−5 versus Ctrl: 2.05 ± 0.24 × 10−5 pg µl−1 neuron−1, t-test, P = 0.001) 
than control lines, strongly suggesting that the TS mutation leads to increased TH expression 
and to an excess secretion of catecholamines (Fig. 4e).
We next investigated the cellular identity of neurons that produce TH in TS and control 
cultures. In both control and TS cultures, TH expressing neurons were not stained with 
antibodies to FOXA2 or EN1, markers of midbrain neurons, or GABA, a marker for 
dopaminergic olfactory neurons in the forebrain (Fig. 4f). Using Fluidigm chip analysis we 
found that TH expression was not confined to any specific class of neurons, although these 
cells were more likely to co-express excitatory markers and dopamine-related genes (Fig. 
4g). This suggests that the TS channel does not promote a catecholaminergic cell fate, but 
instead increases the expression of TH in a variety of cortical cell types. Interestingly, we 
did not observe an increase in TH staining in the cortex of transgenic mice expressing the 
TS channel. This likely reflects the low homology between the promoter regions of the 
mouse and human TH genes and differences in gene regulation27,28.
Finally, to determine if the increase in TH expression in TS neurons was reversible and a 
result of L-type channel activity, we treated 39 day-old neurons from TS individuals with L-
type channel blockers. The conventional L-type calcium channel blocker nimodipine failed 
to reverse the excess expression of TH in these neurons. Earlier studies in cardiomyocytes12 
from TS individuals indicated that roscovitine2,3,29, a cyclin-dependent kinase blocker that 
also increases L-type channel inactivation, can reduce the prolongation of the cardiac AP in 
cells from TS individuals. Treatment with roscovitine caused a 68% reduction in the 
proportion of TH+ neurons (Fig. 4h,i; two-way ANOVA, P < 0.01, n = 3,975 neurons from 
three TS lines and n = 2,679 from three control lines) without affecting the fraction of 
MAP2 expressing cells. This result suggests that the increase in TH expression probably 
results from lack of inactivation of the TS channels and, further, that restoring channel 
inactivation in mature neurons can decrease the abnormal expression of TH in patient cells.
In this study we show that neurons from patient-derived iPSCs can be used to identify 
cellular phenotypes associated with a neurodevelopmental disorder. These findings provide 
insight both into the function of Cav1.2 in the developing human brain and its role in the 
pathogenesis of psychiatric diseases. We report an increase in the amplitude of Ca2+ 
elevations in TS derived NPCs and neurons indicating that loss of inactivation in a single 
splice variant of Cav1.2 can have profound effects on neuronal signaling. A consequence of 
this defect was a change in activity-dependent gene expression and an increase in cells 
producing norepinephrine and dopamine, consistent with previous experiments showing that 
dopaminergic specification is activity dependent39. The TS mutation also caused a decrease 
in neurons expressing SATB2, a marker for callosal projection neurons. This finding is 
unexpected because Cav1.2 has not been previously linked to the specification of these cells. 
The increase in SATB2 expressing cells was recapitulated in the cortex of a mouse 
expressing the TS channel. However, this mouse did not show an increase in TH expression 
probably reflecting species-specific differences in gene regulation and the structure of the 
TH promoter27,28.
Paşca et al. Page 5









A key question is whether these cellular defects help to explain developmental delay and 
ASD in individuals with TS. The reduction in cortical projecting neurons in TS is consistent 
with the emerging view that ASDs arise from defects in connectivity between cortical 
areas30,31, and agrees with studies that show a decreased size of the corpus callosum in 
ASD32. Ectopic production of TH and a subsequent increase in catecholamine synthesis 
agrees with findings from valproic-acid based models of ASD33 and postmortem studies of 
patients with schizophrenia34. As catecholamines play an important role in sensory gating 
and in social behavior, an increase in their synthesis might be important in the 
pathophysiology of ASDs.
ONLINE MATERIALS AND METHODS
iPSC maintenance
Human iPSCs and the embryonic H9 line were cultured on irradiated DR4 mouse embryonic 
fibroblast feeders.
Neural differentiation protocol
Neural differentiation was carried out using a modified version of a previously described 
protocol13. Briefly, the iPSCs were suspended to generate embryoid bodies (EBs) and plated 
to produce neural rosettes (Fig. 1a upper). The rosettes were mechanically isolated and 
expanded as neurospheres, and then either purified by fluorescence activated cell sorting 
(FACS) using the forebrain progenitor marker FORSE-135,36 or plated for differentiation 
into neurons. Seven days after plating of the neurospheres, MAP2ab positive cells were 
observed migrating away from radial clusters of undifferentiated precursors expressing the 
dorsal forebrain marker PAX6 (Fig. 1a middle). After 43 of differentiation in vitro days 
significant numbers of cells expressing the cortical marker DCX (Supplementary Fig. 3) and 
the mature form of MAP2 were observed in the cultures (Fig. 1a lower). Five independent 
differentiations were performed with four control lines, four TS lines, one 22q11 deletion 
syndrome line, and one human ESC line (H9). Each line was differentiated at least twice. In 
addition, two more control lines and one TS line were used for the rescue experiment (see 
also Supplementary Table 1). R-roscovitine (Sigma-Aldrich, R7772) was dissolved in 
DMSO. Neuronal cultures were treated with roscovitine or with the same volume of DMSO 
at day 39 and day 41. Analyses of neuronal cultures were performed at day 43 of 
differentiation.
Calcium Imaging
NPCs (at passage two after plating of the neurospheres) or neuronal cultures at day 43 of 
differentiation, were loaded with 1 µM Fura-2 acetoxymethyl ester (Invitrogen) for 30 min 
at 37°C in Neurobasal/B27 media, washed with Tyrode's solution, and placed in a perfusion 
chamber on the stage of an inverted fluorescence microscope (TE2000U; Nikon). Cells were 
stimulated with high KCl Tyrode's solution (67 mM NaCl, 67 mM KCl for neurons and 100 
mM for NPCs, 2 mM CaCl2, 1 mM MgCl2, 30 mM glucose, and 25 mM Hepes, pH 7.4) 
without or with nimodipine (final concentration 5 µM). Imaging was performed at room 
temperature on an epifluorescence microscope equipped with an excitation filter wheel and 
an automated stage. Openlab software (PerkinElmer) software was used to collect and 
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quantify time-lapse excitation ratio images. Fluorescence images were analyzed using IGOR 
Pro software (WaveMetrics) software.
Single cell qPCR
Neuronal cultures at day 45 of differentiation were rinsed with HBSS and incubated with 
Accutase (StemCell Technologies). After one wash with fresh Neurobasal medium 
(Invitrogen), cells were resuspended in Neurobasal/B27 medium containing 1µg ml−1 
propidium-iodide (Molecular Probes) and filtered through a 40 µm nylon cell strainer (BD 
Biosciences). Clone sorting in 96-well qPCR plates (Eppendorf) was performed at the 
Stanford Shared FACS Facility on a BD Influx cell sorter. Cells were sorted into 10 µl pre-
amplification mix containing 40 nM of all primers for the 96 genes of interest, and the 
following components of the CellsDirect One-Step qRT-PCR Kit (Invitrogen): 2× Reaction 
Mix, SuperScript III RT/Platinum Taq Mix. After sorting, samples were reverse transcribed 
and pre-amplified for 18 cycles. Pre-amplified samples were diluted (2×) with TE buffer and 
stored at −20°C. Sample and assay (primer pairs) preparation for 96.96 Fluidigm Dynamic 
arrays was done according to the manufacturer’s recommendation. Briefly, the sample was 
mixed with 20× DNA Binding Dye Sample Loading Reagent (Fluidigm Corp.), 20× 
EvaGreen (Biotium) and TaqMan® Gene Expression Master Mix (Applied Biosystems). 
Assays were mixed with 2× Assay loading reagent (Fluidigm Corp.) and TE to a final 
concentration of 5 µM. The 96.96 Fluidigm Dynamic Arrays (Fluidigm Corp.) were primed 
and loaded on an IFC Controller HX (Fluidigm Corp.) and qPCR experiments were run on a 
Biomark System for Genetic Anaylsis (Fluidigm Corp.). See Supplementary Methods for 
details on analysis.
Microarrays
RNA from fibroblasts, iPSCs, NPCs, neurons at rest or neurons stimulated with KCl (day 43 
of differentiation), was isolated using the RNeasy Mini kit and the RNase-Free DNase set 
(Qiagen). Total RNA (200 ng) was amplified, labeled, and hybridized on Illumina 
HumanRef-8 v3 Expression BeadChips (Illumina Inc, San Diego, CA) according to the 
manufacturer’s protocol. Data analysis was performed using the Lumi R37 and Bioconductor 
(www.bioconductor.org) packages, as we have previously shown38. Briefly, absolute 
expression values were log2 transformed and normalized using quantile normalization. Data 
quality control measures included inter-array Pearson correlation, clustering based on most 
variable genes (coefficient of variance > 0.05), and detection of outlier arrays, as well as 
probe detection (P values < 0.05). Differential expression analysis was performed using 
Significance analysis of Microarrays (http://www-stat.stanford.edu/~tibs/SAM/). The 
statistical criteria for differential expression were FDR < 0.05 and fold change > 1.3. 
Microarray data is available at GEO (accession code GSE25542).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Characterization of iPSC-derived NPCs and neurons
(a) Immunostaining of neural rosettes (upper: PAX6, N-Cadherin, Hoescht; scale bar is 100 
µm), neurons (MAP2) and progenitors (PAX6) after plating of the neurospheres (middle, 
scale bar 100 µm) and cultures at day 43 of differentiation (lower: MAP2, Hoescht; scale bar 
is 200 µm). The middle image is from a Timothy syndrome–derived culture, and the other 
two are from cultures derived from control individuals. (b) Single cell gene expression 
analysis (Fluidigm) of the population of cells at 45 days of differentiation. Shown are the 
proportion of cells that express a cell-specific marker (mean ± s.e.m.; n = 269 cells from 
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three control iPSC lines). The lower panel shows gene expression profiles of single neurons. 
(c) Scheme illustrating marker gene expression in upper and lower layers of the human 
cortex. (d) Fraction of neurons (NCAM+) expressing lower (FOXP1+/ETV1+) or upper layer 
(FOXP1–/ETV1–) cortical markers as assessed by Fluidigm (mean ± s.e.m; n = 116 cells 
from three controls iPSC lines). (e) Fraction of subpopulations of upper and lower layer 
neurons (NCAM+) expressing CTIP2 or SATB2. (f) Representative current clamp recordings 
(holding potential −65 mV; 1s current pulses, ΔIinj = 5–10 pA) from TS and control derived 
neurons. (g) APs recorded from TS neurons were significantly wider. (h) Representative 
images of control and TS neurons expressing YFP under the control of the Synapsin-1 
promoter (scale bars are 50 µm). (i) Average [Ca2+]i measurements in Synapsin-1 
expressing neurons depolarized twice with 67 mM KCl and treated with 5 µM nimodipine 
(TS; n = 10 neurons; Ctrl; n = 9 neurons). (j) Histogram of residual [Ca2+]i ([C–A]/[B–A]) 
in neurons (three TS lines, three control lines, t-test, P < 0.0001; see also Supplementary 
Fig. 8c).
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Figure 2. Characterization of NPCs and neurons derived from TS individuals and controls by 
genome-wide microarrays
(a) Principal component analysis of whole-genome gene expression profiles for fibroblasts, 
iPSC, embryonic stem cells (ESC), NPCs and neurons showing clustering of cell types 
based on the first two principal components (PC1 and PC2). (b) Heatmaps depicting 
expression levels of genes differentially expressed between TS and control NPCs and 
neurons. Each column represents an independent differentiation of an iPSC line. Genes that 
are highly expressed in TS cells relative to controls are shown in red. Dendrograms show 
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hierarchical clustering of samples based on differentially expressed genes. (c) and (d) List of 
top 20 genes showing the highest expression differences between TS and control cells (c, 
progenitors; d, neurons). (e) Differentially expressed genes in TS neurons relative to control 
neurons after electrical stimulation. (f) Scheme illustrating interactions between a subset of 
calcium regulated genes upregulated in TS (shown in green).
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Figure 3. Characterization of neuronal subpopulations differentiated from TS and control iPSCs
(a) Single cell qPCR analysis (Fluidigm) showing the proportion (mean ± s.e.m., *P < 0.05, 
Chi-square test) of NCAM+ neurons expressing subtype-specific markers, for control (n = 
125 cells, three lines) and TS cultures (n = 140 cells, three lines). (b) Fraction of neurons 
expressing upper and lower cortical layer makers in TS (n = 125 cells) and control cortical 
cultures (n = 116 cells; mean ± s.e.m. *P < 0.05, Chi-square test). (c) Fraction of neurons 
expressing SATB2 and CTIP2 and either lower or upper layer cortical markers in TS and 
control cultures (mean ± s.e.m. *P < 0.05, Chi-square test). (d) 50× image of Satb2 stained 
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cortical sections from a control mouse and a mouse expressing the TS channel in the 
forebrain showing a decrease in Satb2+ cells. Scale bar is 500 µm. (e) Image of Satb2 
stained cortical sections from control and TS mouse at P0.5 (scale bar is 50 µm). (f) 
Measurement of the number of Satb2+ cortical neurons in cortical sections from TS and 
control mice (mean ± s.e.m.; TS: n = 12 animals, Ctrl: n = 14 animals; two-way ANOVA, P 
= 0.001; asterisk denotes P < 0.05 for posthoc analysis) (g) Distribution of Foxp1+ neurons 
in cortical sections from TS and control mice (mean ± s.e.m.; n = 5 animals per group; two-
way ANOVA, P > 0.05).
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Figure 4. Abnormal expression of TH in neurons from TS individuals
(a) Fold changes in TH and MAP2 mRNA levels in TS and control neurons after nine hours 
of depolarization with 67 mM KCl. (b) TS neuronal cultures contain an excess number of 
TH+ neurons (*P < 0.001, t-test). (c) The proportion of TH+ neurons (TH+/MAP2+) is 
shown for three control lines from two healthy individuals (IM23-9, IM23-16, NH2-6), one 
line derived from a individual with 22q11.2 deletion syndrome, and four TS lines from two 
individuals (T7643-5, T7643-7, T7643-32, T9862-42). (d) Representative images of neurons 
stained with TH and MAP2 specific antibodies and Hoechst 33258 (scale bars are 200 µm). 
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(e) Norepinephrine (NE, *P = 0.004) and dopamine (DA, *P = 0.001) levels are elevated in 
media collected from TS neuronal cultures relative to controls. Inset shows an HPLC 
chromatogram with the peaks for NE and DA. (f) TH+ neurons (green) in TS cultures 
(T7643-32 line is shown) are not immunostained by antibodies to FOXA2 (left, blue) or 
GABA (right, red). Scale bar is 50 µm. (g) Fraction of TH+ or TH− neurons from TS 
individuals that co-express other neuronal marker genes (mean ± s.e.m.,* P < 0.05, Chi-
square test). (h) Cultures of TS neurons treated with roscovitine (15 µM at day 39 and 10 
µM at day 41) or DMSO and stained with TH and MAP2 specific antibodies at day 43 of 
differentiation. Scale bar is 200 µm. (i) Proportion of TH+ neurons (TH+/MAP2+) in control 
and TS cultures after treatment with roscovitine or DMSO (mean ± s.e.m., two-way 
ANOVA, **P < 0.001).
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